Impact of Allergic Rhinitis Symptoms on Quality of Life in Primary Care
The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Abstract
Background: Allergic rhinitis (AR) impairs quality of life (QoL), sleep and work. The Allergic Rhinitis and its Impact on Asthma (ARIA) classification is widely used, but the impact of the different symptoms on QoL is not clear. Objective: To describe characteristics of patients consulting in primary care for AR and to study the impact of AR symptoms and the ARIA classes on QoL. Methods: A multicenter prospective observational cross-sectional study assessed the visual analogue scale (VAS) in the management of AR in 990 patients consulting general practitioners for AR. Patients were classified according to the four classes of ARIA. VAS, Rhinoconjunctivitis Quality of Life Questionnaire (RQLQ) and total symptom score (TSS) for nasal and non-nasal symptoms were evaluated. VAS and TSS measures were compared with RQLQ. Results: Mild intermittent rhinitis was diagnosed in 20% of patients, mild persistent rhinitis in 17%, moderate/severe intermittent rhinitis in 15% and moderate/severe persistent rhinitis in 48%. The presence of treatments did not affect VAS levels. Both severity and duration of rhinitis had an impact on QoL and VAS levels. Ocular symptoms (OR: 2.78, 95% CI: 1.965–3.939) including eyelid edema (OR: 2.07, 95% CI: 1.274–3.360) and asthenia (OR: 2.73, 95% CI: 1.922–3.877) had more impact on RQLQ than nasal obstruction (OR: 1.61, 95% CI: 1.078–2.405) and nasal pruritus (OR 1.45, 95% CI: 1.028–2.042). Sneezing and rhinorrhea did not impact RQLQ. Conclusions: This study confirmed that ocular symptoms and, to a lesser degree, nasal obstruction and pruritus have a significant impact on QoL.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“For example, extranasal symptoms, particularly ocular symptoms, have a significant impact on QOL and should not be ignored in the evaluation and management of AR.681-684”
From International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis (2018) · cites this paper as [681]
In the citing paper
“However, other studies conducted in the primary care setting find little correlation between the intensity of NO measured by the symptoms scale and specific QOL questionnaires in AR (assessed using the Rhinoconjunctivitis Quality of Life Questionnaire [RQLQ]) [87].”
From Position Paper on Nasal Obstruction: Evaluation and Treatment (2018) · cites this paper as [87]
Citations
Cites
Allergic Rhinitis and its Impact on Asthma (ARIA) 2008*
Bousquet, J., Khaltaev, N., Cruz, A. A., Denburg, J., Fokkens, W. J., Togias, A., Zuberbier, T., Baena‐Cagnani, C. E., Canonica, G. W., Van Weel, C., et al. (2008) · Allergy · doi:10.1111/j.1398-9995.2007.01620.x · Cited by 4,729
Self-citationAllergic Rhinitis and Its Impact on Asthma
Bousquet, J., van Cauwenberge, P., & Khaltaev, N. (2001) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2001.118891 · Cited by 3,588
Self-citationDevelopment and testing of a new measure of health status for clinical trials in rhinoconjunctivitis
JUNIPER, E. F., & GUYATT, G. H. (1991) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.1991.tb00807.x · Cited by 811
Bousquet, P. J., Combescure, C., Neukirch, F., Klossek, J. M., Méchin, H., Daures, J. ‐., & Bousquet, J. (2007) · Allergy · doi:10.1111/j.1398-9995.2006.01276.x · Cited by 418
Self-citationSeverity and impairment of allergic rhinitis in patients consulting in primary care
Bousquet, J., Neukirch, F., Bousquet, P. J., Gehano, P., Klossek, J. M., Le Gal, M., & Allaf, B. (2006) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2005.09.047 · Cited by 298
Self-citationCharacteristics of intermittent and persistent allergic rhinitis: DREAMS study group
Bousquet, J., Annesi‐Maesano, I., Carat, F., Léger, D., Rugina, M., Pribil, C., El Hasnaoui, A., & Chanal, I. (2005) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2005.02274.x · Cited by 237
Self-citationPrevalence, classification and perception of allergic and nonallergic rhinitis in Belgium
Bachert, C., Van Cauwenberge, P., Olbrecht, J., & Van Schoor, J. (2006) · Allergy · doi:10.1111/j.1398-9995.2006.01054.x · Cited by 236
Validation of the classification of ARIA (allergic rhinitis and its impact on asthma)
Demoly, P., Allaert, F. ‐., Lecasble, M., Bousquet, J., & PRAGMA (2003) · Allergy · doi:10.1034/j.1398-9995.2003.t01-1-00202.x · Cited by 187
Self-citationImportant research questions in allergy and related diseases: nonallergic rhinitis: a GA2LEN paper
Bousquet, J., Fokkens, W., Burney, P., Durham, S. R., Bachert, C., Akdis, C. A., Canonica, G. W., Dahlen, S. ‐., Zuberbier, T., Bieber, T., et al. (2008) · Allergy · doi:10.1111/j.1398-9995.2008.01715.x · Cited by 178
Self-citationImplementation of guidelines for seasonal allergic rhinitis: a randomized controlled trial
Bousquet, J., Lund, V. J., Van Cauwenberge, P., Bremard‐Oury, C., Mounedji, N., Stevens, M. T., & El‐Akkad, T. (2003) · Allergy · doi:10.1034/j.1398-9995.2003.00076.x · Cited by 171
Self-citation
Cited by
Items 101–200 of 204
Haahr, P. A., Jacobsen, C., & Christensen, M. E. (2019) · International Forum of Allergy & Rhinology · doi:10.1002/alr.22258 · Cited by 15
Cai, X., Afthab, M., Hambo, S., Salem, M., Bhitale, R. R., & Harb, H. (2025) · Epigenomics · doi:10.1080/17501911.2025.2548758 · Cited by 14
“The main symptoms of allergic rhinitis are nasal congestion, watery rhinorrhea, pruritus and paroxysmal sneezing [127].”
Reducing Environmental Allergic Triggers: Policy Issues
Abramson, S. L. (2018) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2017.10.027 · Cited by 14
Mite-Allergic Rhinitis: How to Evaluate Clinical Efficacy in Allergen-Specific Immunotherapy Trials?
Pfaar, O., & van Wijk, R. G. (2015) · Current Treatment Options in Allergy · doi:10.1007/s40521-014-0040-y · Cited by 13
Influence of cigarette smoking on allergic rhinitis: a comparative study on smokers and non-smokers.
Grillo, C., Mantia, I. L., Grillo, C., Ciprandi, G., Ragusa, M., & Andaloro, C. (2019) · Acta bio-medica dell'Ateneo parmense/Acta biomedica · doi:10.23750/abm.v90i7-s.8658 · Cited by 15
“Although AR has different degrees of severity, it impairs quality of life (QoL), sleep, daily activities, and school or work performance (2).”
BackgroundDietary Habits in Children with Respiratory Allergies: A Single-Center Polish Pilot Study
Wasilewska, E., Małgorzewicz, S., Gruchała‐Niedoszytko, M., Skotnicka, M., & Jassem, E. (2020) · Nutrients · doi:10.3390/nu12051521 · Cited by 11
“Among children with allergies, decreased involvement in outdoor activities and increased problems with concentration, sleep problems, and headaches are seen; moreover, children with AR often also suffer from asthma [4].”
BackgroundARIA masterclass 2018: From guidelines to real-life implementation
Hellings, P. W., Seys, S., Mariën, G., Agache, I. O., Canonica, G. W., Gevaert, P., Haahtela, T., Klimek, L., Mullol, J., Pfaar, O., et al. (2019) · Rhinology Journal · doi:10.4193/rhin19.011 · Cited by 14
Self-citationBraido, F., Baiardini, I., Scichilone, N., Musarra, A., Menoni, S., Ridolo, E., Gani, F., Pravettoni, V., Colombo, G., Crivellaro, M., et al. (2014) · Rhinology Journal · doi:10.4193/rhin13.040 · Cited by 11
Park, N., Chung, J. Y., Kim, M. H., & Yang, W. M. (2022) · Frontiers in Allergy · doi:10.3389/falgy.2022.1012183 · Cited by 12
“Along with the airway remodeling, there are conjunctival symptoms including rhinorrhea, nasal itching, rubbing, sneezing, and nasal congestion in the development process of allergic rhinitis (27).”
BackgroundLi, J., Wu, H., Xing, W., Li, X., Han, Z., Ji, R., Deng, Z., Jung, M., Sun, S., Chung, B. I., et al. (2024) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2024.172688 · Cited by 10
Klimek, L., Klimek, F., Bergmann, C., Hagemann, J., Cuevas, M., & Becker, S. (2024) · Allergo Journal International · doi:10.1007/s40629-023-00282-5 · Cited by 11
“Therefore, many patients cannot adequately treat their symptoms with the available monotherapies or their free combination [36, 39] and are not surprisingly dissat-isfied with the symptomatic relief achieved [40].”
Hui, H. K. S., Li, T. S., Lo, W. L. W., Kan, A. K. C., Ho, S. Y., Yeung, W. W. Y., Wong, J. C. Y., Chiang, V., Wong, B. Y. H., & Li, P. H. (2022) · Allergo Journal International · doi:10.1007/s40629-022-00218-5 · Cited by 10
Health-related quality of life and its contributory factors in allergic rhinitis patients in Nigeria
Adebola, S. O., Abidoye, B., Ologe, F. E., Adebola, O. E., & Oyejola, B. A. (2015) · Auris Nasus Larynx · doi:10.1016/j.anl.2015.08.002 · Cited by 11
“The severity and duration of rhinitis have been reported to have an impact on the quality of life and visual analogue scores (VAS) of AR patients [19].”
BackgroundOh, W., Im, Y., & Suk, M. H. (2016) · International Journal of Nursing Studies · doi:10.1016/j.ijnurstu.2016.08.012 · Cited by 11
Ciprandi, G., Tosca, M. A., & Silvestri, M. (2013) · Expert Review of Clinical Immunology · doi:10.1586/1744666x.2014.872034 · Cited by 9
“Both severity and duration of rhinitis had an impact on quality of life and VAS levels [16].”
BackgroundYurttaş, V., Şereflican, M., Erkoçoğlu, M., Dağlı, M., Terzi, E. H., Fırat, T., & Seyhan, S. (2016) · ORL · doi:10.1159/000442353 · Cited by 9
Whalley, D., Petigara, T., Rasouliyan, L., Tobe, K., & Tunceli, K. (2016) · Current Medical Research and Opinion · doi:10.1080/03007995.2016.1251891 · Cited by 9
Scadding, G. K., Price, D. B., El‐Shanawany, T., Ahmed, S. K., Ray, J., Sargur, R. B., & Kumar, N. (2017) · BMJ Open · doi:10.1136/bmjopen-2016-014777 · Cited by 10
The Association Between Serum 25-Hydroxyvitamin D Levels and Patients With Allergic Rhinitis
Bukhari, A. F., Felemban, M. J., & Alem, H. (2020) · Cureus · doi:10.7759/cureus.9762 · Cited by 10
Visual analogue scale. A simple tool for daily treatment monitoring in allergic rhinitis
Sybilski, A. J. (2018) · Pediatria i Medycyna Rodzinna · doi:10.15557/pimr.2018.0030 · Cited by 10
Katsimpris, P., Tripsianis, G., Printza, A., Giotakis, E., Simopoulos, E., Constantinidis, J., & Katotomichelakis, M. (2021) · The Journal of Laryngology & Otology · doi:10.1017/s0022215121004011 · Cited by 11
Escaping the trap of allergic rhinitis
Rossi, O., Massaro, I., Caminati, M., Quecchia, C., Fassio, F., Heffler, E. M., & Canonica, G. W. (2015) · Clinical and Molecular Allergy · doi:10.1186/s12948-015-0023-y · Cited by 10
Dziekanski, M., & Marcelino, T. D. F. (2017) · International Archives of Otorhinolaryngology · doi:10.1055/s-0037-1599095 · Cited by 13
Allergic rhinitis and quality of life
Shilenkova, V. V., & As, L. (2019) · Russian Rhinology · doi:10.17116/rosrino201927041215 · Cited by 9
Prevalence trends and risk factors for allergic rhinoconjunctivitis, asthma and eczema in the UK
Diwakar, L., Subramanian, A., Shah, D., Subramaniam, S., Pelly, V. S., Greenfield, S., Moore, D. M., & Nirantharakumar, K. (2025) · Allergy Asthma and Clinical Immunology · doi:10.1186/s13223-025-00975-2 · Cited by 8
“Other studies have confirmed a reduction in quality of life due to ARC [39, 40] asthma [41, 42] and eczema.”
Bousquet, J. J., Sousa‐Pinto, B., Antó, J. M., Bedbrook, A., Czarlewski, W., Ansotegui, I. J., Bergmann, K., Braido, F., Brussino, L., Cecchi, L., et al. (2024) · Clinical and Translational Allergy · doi:10.1002/clt2.12390 · Cited by 6
Self-citationNeed for medication and stuffy nose predict the severity of allergic rhinitis
Salo, T., Peura, S., Salimäki, J., Maasilta, P. K., Haahtela, T., & Kauppi, P. (2016) · Asia Pacific Allergy · doi:10.5415/apallergy.2016.6.2.133 · Cited by 7
“Visual analogic scale has been used to estimate asthma and rhinitis symptoms but there are no reports on NRS as assessment tool for asthma or rhinitis symptoms [3, 5].”
BackgroundMethodSmoking effects on quality of life of allergic rhinitis patients after sublingual immunotherapy
Katotomichelakis, M., Tripsianis, G., Daniilidi, A., Cassimos, D., Kourousis, C., Vogiatzaki, T., & Danielides, V. (2015) · Rhinology journal · doi:10.4193/rhin14.245 · Cited by 6
“SF-36 is a widely used general-health related survey, already validated in allergic respiratory disease (4), that explores QoL in eight domains covering both physical and mental health from the patient’s point of view with chronic diseases (30,31).”
BackgroundWong, Q. Y. A., Lim, J. J., Ng, J. Y., Malipeddi, P., Lim, Y. Y. E., Sio, Y. Y., & Chew, F. T. (2024) · World Allergy Organization Journal · doi:10.1016/j.waojou.2024.100954 · Cited by 7
“21 – 23 Of the AR classes, MSI AR was the predominant AR phenotype, of which most had suffered from it for at least 10 years.”
BackgroundGloistein, C., Astvatsatourov, A., Allekotte, S., & Mösges, R. (2015) · International Archives of Allergy and Immunology · doi:10.1159/000443273 · Cited by 6
Chong, A. X. J., Alvarado, R., Rimmer, J., Campbell, R. G., Kalish, L. H., Png, L. H., & Harvey, R. J. (2024) · Annals of Otology Rhinology & Laryngology · doi:10.1177/00034894241234593 · Cited by 6
“31 A recent phase 3 trial has demonstrated that upon AIT commencement, AR symptoms were observed to reduce rapidly from as early as 14 weeks into treatment.”
BackgroundIndications for Surgery in Refractory Rhinitis
Wu, A. W., & Ting, J. Y. (2014) · Current Allergy and Asthma Reports · doi:10.1007/s11882-013-0414-4 · Cited by 7
Canonica, G. W., Klimek, L., Acaster, S., Dollner, R., Kaulsay, R., Lo, S. H., Price, D. B., Scadding, G. K., Valovirta, E. J., & Zieglmayer, P. U. (2021) · Current Medical Research and Opinion · doi:10.1080/03007995.2021.1911973 · Cited by 6
Alba, P., Moreno, V., Arias-Irigoyen, J., Antón, M., Parra, A., Gómez-Fernández, M. C., Madariaga, B., Martı́nez, A., & Begoña, L. (2020) · Immunotherapy · doi:10.2217/imt-2019-0187 · Cited by 6
Can a Pretreatment Visual Analog Scale Predict Treatment Outcome in Allergic Rhinitis?
Kirtsreesakul, V., Leelapong, J., & Ruttanaphol, S. (2020) · International Archives of Allergy and Immunology · doi:10.1159/000505745 · Cited by 6
A fifteen‐year review of skin allergy testing in Irish patients with symptomatic rhinitis
Nae, A., Hinchion, K., & Keogh, I. J. (2021) · World Journal of Otorhinolaryngology - Head and Neck Surgery · doi:10.1016/j.wjorl.2020.10.001 · Cited by 7
Son, J., Kim, E., Choi, H., Ha, I., Lee, D., & Lee, Y. J. (2021) · Clinical and Molecular Allergy · doi:10.1186/s12948-021-00158-5 · Cited by 6
Torres, Á. F. (2023) · European Annals of Allergy and Clinical Immunology · doi:10.23822/eurannaci.1764-1489.267 · Cited by 6
“Although these diseases do not usually threat patients’ lives, they can result in considerable morbidity (2, 3) and cause a significant deterioration in patients’ quality of life (QoL) (4, 5).”
(2017) · Rhinology Journal · doi:10.4193/rhino16.025 · Cited by 6
Wongsa, C., Wongyikul, P., Chokevittaya, P., Nititammaluk, A., Sompornrattanaphan, M., Atipas, K., Kasemsuk, N., Kanjanawasee, D., Suwanwech, T., Tantilipikorn, P., et al. (2025) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2025.11.041 · Cited by 5
Bahena-Culhuac, E., & Bello, M. (2024) · Molecules · doi:10.3390/molecules29081765 · Cited by 5
Klimek, L., Bergmann, K., Biedermann, T., Bousquet, J., Hellings, P. W., Jung, K., Merk, H. F., Olze, H., Schlenter, W. W., Stock, P., et al. (2018) · Allergologie · doi:10.5414/alx02047 · Cited by 5
Self-citationZhu, Z., Xie, Y., Guan, W., Gao, Y., Xia, S., Shi, X., & Zheng, J. (2016) · Asia Pacific Allergy · doi:10.5415/apallergy.2016.6.4.245 · Cited by 4
“As previously reported our results also showed that nasal symptom severity (nasal congestion, rhinorrhea, and nasal pruritus) in the previous week has an impact on QoL, especially on the dimensions of practical, nasal, and ocular problems in RQoLQ [15].”
ResultAriaee, N., Panahi, M., Bakhshaee, M., Ghorbani, J., Ravanshad, Y., Hosseini, R. F., Ranjbar, A., & Jabbari, F. (2021) · Advances in Dermatology and Allergology · doi:10.5114/ada.2020.102295 · Cited by 6
Ariaee, N., Ghorbani, J., Panahi, M., Mohammadi, M., Asili, J., Ranjbar, A., Hoseini, R. F., & Jabbari, F. (2018) · Europe PMC (PubMed Central) · Cited by 5
Patients’ perspective on allergen immunotherapy for respiratory allergy
Catamerò, F., Barbaglia, S., Heffler, E. M., Giovannini, M., & Paoletti, G. (2025) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/aci.0000000000001110 · Cited by 5
ARIA 2019: Um Percurso Assistencial Integrado para a Rinite Alérgica em Portugal
Fonseca, J., Taveira‐Gomes, T., Pereira, A. M., Ferreira, M. B., Martins, P., Alves‐Correia, M., de Sousa, J. C., Costa, E. M., Lourenço, O. M., Morais‐Almeida, M., et al. (2020) · Acta Médica Portuguesa · doi:10.20344/amp.13777 · Cited by 8
Self-citationMarth, K., Renner, A., Langmayr, G., Pohl, W., Nguyen, D. T., & Kuhl, H. C. (2024) · Drugs - Real World Outcomes · doi:10.1007/s40801-023-00412-z · Cited by 5
“The increasing prevalence of AR [4, 5] is troubling because of associated morbidities that reduce patients’ quality of life [6, 7] and impair school and work performance [8–10].”
BackgroundProteomic analysis of human nasal mucosa: different expression profile in rhino-pathologic states.
Gelardi, M., Siciliano, R. A., Papa, F., Mazzeo, M. F., Nitto, E. D., Quaranta, N. A. A., & Lippolis, R. (2014) · PubMed · Cited by 4
Control of allergic rhinitis with MP-AzeFlu: a noninterventional study of a Swedish cohort
Stjärne, P., Strand, V., Theman, K., & Ehnhage, A. (2019) · Rhinology Journal · doi:10.4193/rhin18.028 · Cited by 6
Advanced Therapy of Allergic Rhinitis: Possibilities, Limitations and Prospects
Nosulya, E. V., Kim, I. A., Kunelskaya, V. Y., & Luchsheva, Y. V. (2023) · Russian Rhinology · doi:10.17116/rosrino20233101154 · Cited by 4
Bergmann, K., & Zuberbier, T. (2025) · Allergy · doi:10.1111/all.70045 · Cited by 3
“ARC imposes a significant economic burden on healthcare systems, warranting alternative approaches to ARC management [9–12, 37, 38].”
Santaolalla, M., Arias-Irigoyen, J., Soler, J. M., Duque, J. M., Escudero, R., Pérez‐Formoso, J. L., Lobera, T., Rueda, M., Alías, C., Hermida, H., et al. (2024) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2024.2373886 · Cited by 7
“AR can very rarely be a cause of death, although can cause a significant deterioration in patients’ QoL [5,6].”
Modern approaches to rational combination pharmacotherapy of allergic rhinitis
Zyryanov, S. K., & Vozzhaev, A. V. (2024) · Russian Bulletin of Otorhinolaryngology · doi:10.17116/otorino20248904168 · Cited by 3
Damask, C. C. (2017) · Otolaryngologic Clinics of North America · doi:10.1016/j.otc.2017.08.012 · Cited by 3
Zu, B., Li, X., Li, Y., Wang, H., & Li, J. (2025) · Neurocomputing · doi:10.1016/j.neucom.2025.130892 · Cited by 2
Clinical Evaluation of Allergen Immunotherapy for Allergic Rhinitis
Catamerò, F., Bragato, M. C., Lozano, M. A., Canonica, G. W., Hernández, D. B., Escribese, M. M., Heffler, E. M., Pfaar, O., Şahiner, Ü. M., Paoletti, G., et al. (2026) · Vaccines · doi:10.3390/vaccines14040326 · Cited by 6
Quel stress pour les allergiques ?
Wassenberg, J., & Bergmann, M. M. (2013) · Revue française d'allergologie · doi:10.1016/j.reval.2013.01.018 · Cited by 2
Zhu, Z., Xie, Y., Guan, W., Gao, Y., Xia, S., Huang, R., Zhong, N., & Zheng, J. (2016) · The Clinical Respiratory Journal · doi:10.1111/crj.12566 · Cited by 2
“Email: jpzhenggy@163.com Background: Both histamine and leukotrienes are implicated in the pathogenesis of allergic rhinitis (AR), although the pattern and severity of the nasal response to these two potent inflammatory mediators may differ, which has not been adequately studied in patients with persistent AR. Objecti…”
MethodInfluentialAllergic rhinitis and comorbid diseases. Otorhinolaryngologist’s view. Case report
Shilenkova, V. V. (2022) · Consilium Medicum · doi:10.26442/20751753.2022.9.201868 · Cited by 2
Mishra, N., Peralam, P. Y., Dongre, A., Singh, R., Goswami, K., Ray, B., Nagaraju, L. M. K., Ghosh, D., Patra, J., & Vivekprana, P. (2023) · Indian Journal of Community Medicine · doi:10.4103/ijcm.ijcm_251_22 · Cited by 3
“[6] The risk of development of asthma is higher among the children with onset early in life and inappropriate treatment, which also reduces the quality of life for these children.[7] Thus, there is a need to detect the AR early for provision of appropriate clinical and preventive care.”
BackgroundCui, W., Gao, H., Zhu, L.-R., Xu, Y., & Liu, H. (2024) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2024.117590 · Cited by 4
Variations in the Severity of Rhinitis Symptoms: A Systematic Review and Meta‐Analysis
Ripp, A. T., Patel, P. A., Nguyen, S. A., Schafer, I. V., Duffy, A. N., Soler, Z. M., & Schlosser, R. J. (2025) · World Journal of Otorhinolaryngology - Head and Neck Surgery · doi:10.1002/wjo2.70034 · Cited by 2
ARIA-Versorgungspfade für die Allergenimmuntherapie 2019
Bousquet, J. J., Pfaar, O., Togias, A. G., & al, E. (2019) · Allergologie · doi:10.5414/alx02096 · Cited by 2
Self-citationИММУНОЛОГИЧЕСКИЕ АСПЕКТЫ ЭФФЕКТИВНОСТИ АЛЛЕРГЕН-СПЕЦИФИЧЕСКОЙ ИММУНОТЕРАПИИ. ОБЗОР ЛИТЕРАТУРЫ.
Izmailovich, M. R., Газалиева, М. А., Glushkova, N., Dedova, O. Y., С.Т., М., & А.В., С. (2020) · Ġylym men densaulyķ saķtau. · doi:10.34689/sh.2020.22.2.004 · Cited by 3
Fokkens, W. J., Hellings, P. W., Mullol, J., Munzel, U., & Bachert, C. (2015) · Clinical and Translational Allergy · doi:10.1186/2045-7022-5-s4-p33 · Cited by 2
Scadding, G. K. (2020) · Frontiers in Allergy · doi:10.3389/falgy.2020.584518 · Cited by 3
“Treatment of AR is no longer simple as the disease has become more severe and complex in recent decades with many sufferers being polysensitized (8, 16) having moderate/severe disease (1, 17, 18) and persistent symptoms (19).”
BackgroundQualidade de vida e do sono em pacientes com rinite no Oeste da Bahia
Ferreira, J. A., Knupp, L. D. V. G., Gomes, D. R., de Souza, T. M. O., & Mattos, M. P. (2022) · Revista de Ciências Médicas e Biológicas · doi:10.9771/cmbio.v20i4.37132 · Cited by 2
Azelastine and fluticasone nasal spray: any advantage?
(2014) · Drug and Therapeutics Bulletin · doi:10.1136/dtb.2014.2.0237 · Cited by 2
Cai, Y. (2024) · American Journal of Translational Research · doi:10.62347/cpzn1117 · Cited by 1
Jakość życia w alergicznym nieżycie nosa
Pawliczak, R. (2015) · Alergologia Polska - Polish Journal of Allergology · doi:10.1016/j.alergo.2015.11.004 · Cited by 1
Effectiveness of allergic rhinitis treatments in real-life with a focus on MP-AzeFlu
Klimek, L., Demoly, P. M., & Price, D. B. (2016) · Expert Review of Clinical Pharmacology · doi:10.1586/17512433.2016.1148598 · Cited by 1
“In primary care, the AR population comprises mostly of moderate–severe persistent AR (PER; 48%) with the remaining patients divided between mild intermittent AR (IAR; 20%), mild PER (17%), and moderate–severe IAR (15%) [1].”
BackgroundSelf-citationMP29-02 (Dymista®) â Eine neue Behandlungsoption für die allergische Rhinitis
Klimek, L., Bachert, C., Wagenmann, M., Ring, J., & Pfaar, O. (2014) · Allergologie · doi:10.5414/alx01606 · Cited by 1
Effects of Auricular Acupressure on Symptoms and Quality of Life of Patients with Allergic Rhinitis
Lee, H., & Park, H. (2018) · Journal of Korean Academy of Fundamentals of Nursing · doi:10.7739/jkafn.2018.25.3.197 · Cited by 1
Sajad, Q., Musani, A., & Khan, F. A. (2019) · Journal of Bahria University Medical and Dental College · doi:10.51985/jbumdc2018091 · Cited by 1
Clinical Signs in Allergic Rhinitis Patients at Dr. Hasan Sadikin General Hospital Bandung 2017-2021
Wibowo, E. B., Dermawan, A., & Sudiro, M. (2022) · Althea Medical Journal · doi:10.15850/amj.v9n3.2682 · Cited by 3
Plosker, G. L., & Lyseng-Williamson, K. A. (2015) · Drugs & Therapy Perspectives · doi:10.1007/s40267-015-0254-5 · Cited by 1
“Ocular symptoms have a significant negative impact on healthrelated quality of life (HR-QOL) in patients with allergic rhinitis, and, for the individual symptom of itchy eyes, which has been shown to have a marked negative effect on HR-QOL [1], the improvement from baseline with MPAzeFlu was significantly (p B 0.01) g…”
BackgroundInfluentialFontaine, J. F., Elias-Billon, I., Nexon, M.-P., & Allaert, F. (2016) · Revue française d'allergologie · doi:10.1016/j.reval.2016.10.011 · Cited by 1
Baptist, A. P., & Nyenhuis, S. M. (2018) · Springer eBooks · doi:10.1007/978-3-319-75370-6_12 · Cited by 2
Characteristics of the treatment of perennial allergic rhinitis in patients of the older age group
Sapova, K. I., & Ryazantsev, S. V. (2018) · Meditsinskiy sovet = Medical Council · doi:10.21518/2079-701x-2018-20-107-110 · Cited by 1
Mometasone furoate in the treatment of allergic rhinitis: a complex therapeutic effect
Fassakhov, R. S., & Marapov, D. I. (2021) · Meditsinskiy sovet = Medical Council · doi:10.21518/2079-701x-2021-12-130-137 · Cited by 1
Prise en charge de la rhinite allergique : une question d’actualité
Lavaud, F., & Dutau, G. (2015) · Revue française d'allergologie · doi:10.1016/j.reval.2015.09.001 · Cited by 1
Bachert, C., & Cardell, L. (2014) · Clinical Practice · doi:10.2217/cpr.14.41
Verquollene Augen — ein unterschätztes Symptom
Oberhofer, E. (2013) · Allergo Journal · doi:10.1007/s15007-013-0011-9
Klimek, L., Bergmann, K., Biedermann, T., Bousquet, J., Hellings, P. W., Jung, K., Merk, H. F., Olze, H., Schlenter, W. W., Stock, P., et al. (2017) · Allergo Journal · doi:10.1007/s15007-017-1228-1
Self-citationBechraoui, R., Toujani, S., Tbini, M., Dhaha, M., Mediouni, A., Mjid, M., Amor, M. B., Beltaief, N., Zainine, R., & Besbes, G. (2019) · Revue française d'allergologie · doi:10.1016/j.reval.2018.11.005
Health‐Related Quality of Life and Its Contributory Factors in Allergic Rhinitis Patients in Nigeria
Adebola, S. O., Abidoye, B., Ologe, F. E., Adebola, O. E., & Oyejola, B. A. (2014) · Otolaryngology · doi:10.1177/0194599814541627a285
Agarwal, A. K., Sharma, R., & Sharma, V. (2020) · International Journal of Otorhinolaryngology and Head and Neck Surgery · doi:10.18203/issn.2454-5929.ijohns20202205
Khadeer, S., & Jagannath, B. (2021) · IP Journal of Otorhinolaryngology and Allied Science · doi:10.18231/j.ijoas.2021.021
Usefulness of Checking Sensitization Status in Adult Patients with Suspected Sleep Apnea
Gouder, C., Montefort, S., & Bartra, J. (2022) · Indian Journal of Sleep Medicine · doi:10.5005/jp-journals-10069-0085
Vladimirova, T. Y., Popova, A. M., & Popov, M. N. (2022) · Meditsinskiy sovet = Medical Council · doi:10.21518/2079-701x-2022-16-8-106-110
Klimek, L., Klimek, F., Bergmann, C., Hagemann, J., Cuevas, M., & Becker, S. (2024) · Allergo Journal · doi:10.1007/s15007-023-6204-y
A Survey on Seasonal Symptoms in Subjects with and Without Allergic Rhinitis Diagnosis
Helbling, A., Foglierini, M., Colin, V., Müller, Y. D., Schuller, E., Stern, A., & Strub, K. (2025) · Allergies · doi:10.3390/allergies5010007
“A more recent survey in France showed that patients with AR retain symptoms and report relevant disease burden despite ongoing treatment [27].”
A Streamlined Treatment Algorithm for Allergic Rhinitis in the Arab Region: Expert Panel Opinion
Armouch, M., Atef, A. M., Hameed, O. A. A., Alshaikh, N., Elbeleidy, A. S., Ali, B., Najjar, L. E., & Tawfik, E. (2025) · Cureus · doi:10.7759/cureus.82836 · Cited by 1
“Disease burden and impact on QoL: Many AR patients have an impaired QoL since the disease significantly impacts their sleep quality and cognitive function and causes irritability and fatigue [15,16].”
Quản, T. N., Nghiêm, Đ. T., Nguyễn, T. H., & Nguyễn, Q. T. (2025) · VietNam Military Medical Unisversity · doi:10.56535/jmpm.v50i5.1215
Agarwal, J., Ramalingam, R. K., Kopietz, F., AlRuthia, Y. S., & Thompson, R. (2025) · Current Medical Research and Opinion · doi:10.1080/03007995.2025.2583563 · Cited by 1
“Persistent symptoms lead to fatigue, sleep disturbances, and cognitive impairment, thereby diminishing the quality of life 18 .”
Yin, Z., Geng, G., Xu, G., Zhao, L., & Liang, F. (2020) · Figshare · doi:10.6084/m9.figshare.13083035
Son, J., Kim, E.-S., Choi, H.-S., 하인혁, Lee, D., & Lee, Y. J. (2021) · Figshare · doi:10.6084/m9.figshare.16786755
Zu, B., Li, X., Li, Y., Li, J., & Wang, H. (2026) · Applied Soft Computing · doi:10.1016/j.asoc.2026.114774
Metadata
- Authors
- Bousquet, P. J., Demoly, P., Devillier, P., Mesbah, K., & Bousquet, J.
- Affiliations
- Inserm (FR)
- Université de Versailles Saint-Quentin-en-Yvelines (FR)
- MSD (France) (FR)
- Venue
- International Archives of Allergy and Immunology
- Publisher
- S. Karger AG
- Published
- 2012-11-23
- Volume
- 160
- Issue
- 4
- Pages
- 393-400
- ISSN
- 1018-2438 (ISSN-L)
- 1423-0097
- OpenAlex
- W2046440947
- Cited by
- 204
- References
- 37
- Citations by year
- 2026: 6 · 2025: 11 · 2024: 13 · 2023: 7 · 2022: 11 · 2021: 12 · 2020: 22 · 2019: 17 · 2018: 20 · 2017: 17 · 2016: 21 · 2015: 22 · 2014: 17 · 2013: 7
- FWCI
- 10.84
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.karger.com/Services/SiteLicenses (vor)
- www.karger.com/Services/SiteLicenses (tdm)
- Locations
- International Archives of Allergy and Immunology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Immunology and Allergy › Allergic Rhinitis and Sensitization
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Asthma and respiratory diseases
- Health Sciences › Medicine › Immunology and Allergy › Food Allergy and Anaphylaxis Research
- Keywords
- allergic rhinitis, quality of life, ARIA classification, Rhinoconjunctivitis Quality of Life Questionnaire, ocular symptoms, eyelid swelling, asthenia, nasal obstruction, nasal pruritus, sneezing, rhinorrhea, persistent rhinitis, primary care patients
- MeSH terms
- Adolescent, Adult, Aged, Aged, 80 and over, Asthma, Cross-Sectional Studies, Female, Humans, Male, Middle Aged, Pain Measurement, Primary Health Care, Prospective Studies, Quality of Life, Surveys and Questionnaires, Rhinitis, Allergic, Perennial, Severity of Illness Index, Nasal Obstruction, Young Adult, Rhinitis, Allergic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.